IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 252 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191,348 | -36.3% | 19,870 | -29.6% | 0.04% | -53.4% |
| Q2 2023 | $300,261 | +6.7% | 28,220 | +5.5% | 0.09% | -2.2% |
| Q1 2023 | $281,410 | -14.3% | 26,750 | +1.0% | 0.09% | -17.4% |
| Q4 2022 | $328,298 | +35.7% | 26,497 | +13.3% | 0.11% | -8.4% |
| Q3 2022 | $242,000 | +8.0% | 23,387 | +20.5% | 0.12% | -14.4% |
| Q2 2022 | $224,000 | +23.1% | 19,409 | +33.8% | 0.14% | +52.7% |
| Q1 2022 | $182,000 | +15.2% | 14,504 | +7.4% | 0.09% | +24.7% |
| Q4 2021 | $158,000 | +364.7% | 13,503 | +422.6% | 0.07% | +231.8% |
| Q3 2021 | $34,000 | -50.0% | 2,584 | -51.4% | 0.02% | -48.8% |
| Q2 2021 | $68,000 | +223.8% | 5,316 | +183.2% | 0.04% | +26.5% |
| Q1 2021 | $21,000 | – | 1,877 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |